| Dr Katherine Eckstein, MD | |
|
700 West Ave S, La Crosse, WI 54601-4783 | |
| (608) 785-0940 | |
| Not Available |
| Full Name | Dr Katherine Eckstein |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 700 West Ave S, La Crosse, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275797813 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301092411 (Michigan) | Secondary |
| 207P00000X | Emergency Medicine | 60773 (Wisconsin) | Primary |
| Entity Name | Mayo Clinic Health System-franciscan Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629056049 PECOS PAC ID: 0345152443 Enrollment ID: O20031110000684 |
News Archive
Many drug-resistant infections are the result of bacterial biofilms, structured aggregates of bacteria that live on surfaces and that are extremely resistant to environmental stresses. These biofilms impact human health in many ways - cystic fibrosis, for example, is a disease in which patients die from airway bacterial biofilm infections that are invulnerable to even the most potent antibiotics.
Anglers rely on fish finders to help them locate the big catch. Now Tel Aviv University researchers in tissue engineering have developed a "fat finder" that can help scientists accelerate their research into new fat-melting drugs.
A new study by a Ben-Gurion University of the Negev (BGU) researcher reveals a linkage between elderly people's appetite and mortality rates, with those who report impaired appetite more likely to die sooner.
Trevena, Inc., the leader in discovery and development of G-protein coupled receptor biased ligands, announced today that it has completed a $35 million Series B financing. Existing investors Polaris Venture Partners and New Enterprise Associates led the round, with all other existing Trevena investors - Alta Partners, Healthcare Ventures and Yasuda Enterprise Development Company - also participating in the financing.
Trovagene, Inc., a developer of transrenal molecular diagnostics, announced it has granted Duke University and Duke University Health Systems a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia (AML).
› Verified 4 days ago
| Entity Name | Mayo Clinic Health System-franciscan Medical Center Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1841278637 PECOS PAC ID: 0345152443 Enrollment ID: O20100506000523 |
News Archive
Many drug-resistant infections are the result of bacterial biofilms, structured aggregates of bacteria that live on surfaces and that are extremely resistant to environmental stresses. These biofilms impact human health in many ways - cystic fibrosis, for example, is a disease in which patients die from airway bacterial biofilm infections that are invulnerable to even the most potent antibiotics.
Anglers rely on fish finders to help them locate the big catch. Now Tel Aviv University researchers in tissue engineering have developed a "fat finder" that can help scientists accelerate their research into new fat-melting drugs.
A new study by a Ben-Gurion University of the Negev (BGU) researcher reveals a linkage between elderly people's appetite and mortality rates, with those who report impaired appetite more likely to die sooner.
Trevena, Inc., the leader in discovery and development of G-protein coupled receptor biased ligands, announced today that it has completed a $35 million Series B financing. Existing investors Polaris Venture Partners and New Enterprise Associates led the round, with all other existing Trevena investors - Alta Partners, Healthcare Ventures and Yasuda Enterprise Development Company - also participating in the financing.
Trovagene, Inc., a developer of transrenal molecular diagnostics, announced it has granted Duke University and Duke University Health Systems a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia (AML).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katherine Eckstein, MD 200 1st St Sw, Rochester, MN 55905-1510 Ph: (608) 785-0940 | Dr Katherine Eckstein, MD 700 West Ave S, La Crosse, WI 54601-4783 Ph: (608) 785-0940 |
News Archive
Many drug-resistant infections are the result of bacterial biofilms, structured aggregates of bacteria that live on surfaces and that are extremely resistant to environmental stresses. These biofilms impact human health in many ways - cystic fibrosis, for example, is a disease in which patients die from airway bacterial biofilm infections that are invulnerable to even the most potent antibiotics.
Anglers rely on fish finders to help them locate the big catch. Now Tel Aviv University researchers in tissue engineering have developed a "fat finder" that can help scientists accelerate their research into new fat-melting drugs.
A new study by a Ben-Gurion University of the Negev (BGU) researcher reveals a linkage between elderly people's appetite and mortality rates, with those who report impaired appetite more likely to die sooner.
Trevena, Inc., the leader in discovery and development of G-protein coupled receptor biased ligands, announced today that it has completed a $35 million Series B financing. Existing investors Polaris Venture Partners and New Enterprise Associates led the round, with all other existing Trevena investors - Alta Partners, Healthcare Ventures and Yasuda Enterprise Development Company - also participating in the financing.
Trovagene, Inc., a developer of transrenal molecular diagnostics, announced it has granted Duke University and Duke University Health Systems a non-exclusive license to incorporate nucleophosmin protein (NPM1) into research and clinical testing services for acute myelogenous leukemia (AML).
› Verified 4 days ago
Raymond D Pollock, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 West Ave S, La Crosse, WI 54601 Phone: 608-392-7000 Fax: 608-392-7808 | |
Dr. Marvelene Julia Casner, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 West Ave S, La Crosse, WI 54601 Phone: 608-785-0940 | |
Clay Arthur Smith, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 West Ave S, La Crosse, WI 54601 Phone: 605-787-8702 | |
Dr. Leah Rose Moellers Thompson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 | |
Taft Franklin, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 West Ave S, La Crosse, WI 54601 Phone: 608-785-0940 | |
Dr. Gabriel L Marsh, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 | |
Andrew Ronald Jesson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 |